EE223 Economic Consequences of Administering Obinutuzumab as a Short Duration Infusion in Italian Patients With Advanced Follicular Lymphoma: A Cost Analysis
Abstract
Authors
M Bellone L Pradelli R Tavarozzi M Ladetto G Nepoti E Guardalben D Ghislieri